Skip to content

Apotheek Vandenabeele: what changed

What changed

Apotheek Vandenabeele

BE 0794.880.653
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€12,584
2024 · €10,036+€2,548
Equity
€65,209
2024 · €52,626+€12,584
Cash
€51,944
2024 · €83,259-€31,315
Balance sheet total
€509,264
2024 · €522,642-€13,378

Largest movements

2024 to 2025
Assets
  • Cash -€31,315

    down €31,315 (-37.6%), from €83,259 to €51,944

    mainly Other debts (-€52,158) and Receivables within one year (-€28,030)

  • Receivables within one year +€28,030

    up €28,030 (+60.1%), from €46,674 to €74,704

    of which Trade receivables: +€31,373

  • Intangible fixed assets -€25,000

    down €25,000 (-12.5%), from €200,068 to €175,068

  • Stocks and contracts +€9,020

    up €9,020 (+6.0%), from €149,851 to €158,871

  • Deferred charges and accrued income +€7,425

    up €7,425 (+94.1%), from €7,894 to €15,319

Equity and liabilities
  • Other debts -€52,158

    down €52,158 (-12.1%), from €431,412 to €379,254

  • Trade debts +€18,274

    up €18,274 (+70.6%), from €25,881 to €44,155

  • Reserves +€12,584

    up €12,584 (+45.6%), from €27,626 to €40,209

Income statement
  • Gross operating margin +€11,105

    up €11,105 (+7.5%), from €148,421 to €159,526

  • Taxes +€2,964

    up €2,964 (+102%), from €2,894 to €5,858

  • Staff costs +€2,747

    up €2,747 (+2.9%), from €95,675 to €98,422

  • Financial charges +€2,158

    up €2,158 (+25.3%), from €8,527 to €10,686

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €10,036
Gross operating margin +€11,105
Staff costs -€2,747
Depreciation -€215
Other operating charges +€138
Financial income -€611
Financial charges -€2,158
Taxes -€2,964
Result 2025 €12,584
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€28,288
Investment -€3,027
Financing €0
Cash 2024 €83,259
Net result for the year +€12,584
Depreciation +€29,566
Stocks and contracts -€9,020
Receivables within one year -€28,030
Deferred charges and accrued income -€7,425
Trade debts +€18,274
Tax, wage and social debts +€4,872
Other debts -€52,158
Accrued charges and deferred income +€3,050
Investment in fixed assets (net) -€3,027
Cash 2025 €51,944
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €522,642 €509,264 -€13,378 -2.6%
Fixed assets 21/28 €234,964 €208,426 -€26,538 -11.3%
Intangible fixed assets 21 €200,068 €175,068 -€25,000 -12.5%
Tangible fixed assets 22/27 €34,896 €33,358 -€1,538 -4.4%
Plant, machinery and equipment 23 €34,896 €33,358 -€1,538 -4.4%
Current assets 29/58 €287,678 €300,838 +€13,160 +4.6%
Stocks and contracts in progress 3 €149,851 €158,871 +€9,020 +6.0%
Stocks 30/36 €149,851 €158,871 +€9,020 +6.0%
Amounts receivable within one year 40/41 €46,674 €74,704 +€28,030 +60.1%
Trade receivables 40 €41,986 €73,358 +€31,373 +74.7%
Other amounts receivable 41 €4,689 €1,346 -€3,343 -71.3%
Cash at bank and in hand 54/58 €83,259 €51,944 -€31,315 -37.6%
Deferred charges and accrued income 490/1 €7,894 €15,319 +€7,425 +94.1%
Total equity and liabilities 10/49 €522,642 €509,264 -€13,378 -2.6%
Equity 10/15 €52,626 €65,209 +€12,584 +23.9%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €27,626 €40,209 +€12,584 +45.6%
Distributable reserves 133 €27,626 €40,209 +€12,584 +45.6%
Amounts payable 17/49 €470,017 €444,055 -€25,962 -5.5%
Amounts payable within one year 42/48 €470,017 €441,005 -€29,012 -6.2%
Trade debts 44 €25,881 €44,155 +€18,274 +70.6%
Suppliers 440/4 €25,881 €44,155 +€18,274 +70.6%
Taxes, remuneration and social security 45 €12,724 €17,596 +€4,872 +38.3%
Taxes 450/3 €999 €5,858 +€4,860 +487%
Remuneration and social security 454/9 €11,725 €11,738 +€13 +0.1%
Other amounts payable 47/48 €431,412 €379,254 -€52,158 -12.1%
Accrued charges and deferred income 492/3 - €3,050 +€3,050
Remuneration, social security and pensions 62 €95,675 €98,422 +€2,747 +2.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €29,351 €29,566 +€215 +0.7%
Other operating charges 640/8 €3,396 €3,257 -€138 -4.1%
Gross operating margin 9900 €148,421 €159,526 +€11,105 +7.5%
Operating profit (loss) 9901 €20,001 €28,282 +€8,281 +41.4%
Financial income 75/76B €1,456 €846 -€611 -41.9%
Recurring financial income 75 €1,456 €846 -€611 -41.9%
Financial charges 65/66B €8,527 €10,686 +€2,158 +25.3%
Recurring financial charges 65 €8,527 €10,686 +€2,158 +25.3%
Profit (loss) for the period before taxes 9903 €12,930 €18,442 +€5,512 +42.6%
Income taxes 67/77 €2,894 €5,858 +€2,964 +102%
Profit (loss) for the period 9904 €10,036 €12,584 +€2,548 +25.4%
Profit (loss) for the period to be appropriated 9905 €10,036 €12,584 +€2,548 +25.4%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.